Twitxy Saved

CSIRO

This account is verified because it is a government or multilateral organization account. Learn more

@CSIRO

This account has been archived. Visit us at csiro.au/news for our latest updates.
Australia csiro.au Joined August 2010
1.5K Following 117K Followers 35K Posts

Latest posts 5

CSIRO @CSIRO
Science has struggled to explain why some people develop diseases while others who are genetically similar do not.

We now believe that the answer lies in the process, epistasis, where genes impact how others are expressed.

csiro.au/en/news/All/Arโ€ฆ
www.csiro.au Epistasis: Unlocking the secrets of complex diseases Epistasis could answer some of the biggest questions in genetics but unlocking its secrets remains a challenge as researchers tackle complex genetic interactions with statistics and computing.
5 replies 10 reposts 21 likes 9.1K views View on X
CSIRO @CSIRO
Bright sparks wanted. โšก

We've launched a new R&D grant opportunity for mining and manufacturing SMEs.

We'e offering up to $50,000 per project and access to our research facilities and expertise to undertake collaborative graphite R&D projects. csiro.au/en/news/All/Neโ€ฆ
www.csiro.au CSIRO's new graphite R&D grants to supercharge SME battery innovation The opportunity seeks to strengthen Australiaโ€™s battery industry, boosting export opportunities through grants to mining and manufacturing SMEs involved in graphite development and production.
1 replies 6 reposts 18 likes 5.3K views View on X
CSIRO @CSIRO
Making medicine smarter. ๐Ÿ”ฌ

Thanks to breakthroughs in bioconjugation and theranostics, treatments for cancer and diabetes are becoming more precise, reducing side effects and improving outcomes for patients.

@UQ_News @MaterResearch @Sydney_Uni csiro.au/en/news/All/Arโ€ฆ
www.csiro.au A spoonful of science: Bioconjugation helps the medicine go down Advances in bioconjugation and theranostics are enabling precise, targeted therapies for conditions like cancer and diabetes, reducing side effects and improving treatment effectiveness.